SEC Company Response from CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869) (CAPR) — Dec 13, 2019
CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869)
Date: Dec. 13, 2019 · CIK: 0001133869 · Accession: 0001104659-19-072629
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-235358
Letter
Re:
December 13, 2019
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Chris Edwards
Capricor Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-235358
Acceleration Request
Requested Date: December 17, 2019
Requested Time: 5:15 P.M., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Capricor Therapeutics, Inc. (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1, Registration Number 333-235358 (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 5:15 P.M., Eastern Time, on December 17, 2019, or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.
We would appreciated it if, as soon as the Registration Statement is declared effective, you would so inform Rob R. Carlson of Sidley Austin LLP at (650) 565-7129.
Very truly yours,
/s/ Anthony J. Bergmann
Show Raw Text
CORRESP
1
filename1.htm
December 13, 2019
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention:
Chris Edwards
Re:
Capricor Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-235358
Acceleration Request
Requested Date: December 17, 2019
Requested Time: 5:15 P.M., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, Capricor Therapeutics, Inc. (the “Company”), hereby requests
that the effective date of the Company’s Registration Statement on Form S-1, Registration Number 333-235358 (the
“Registration Statement”) be accelerated so that the Company’s Registration Statement will become
effective at 5:15 P.M., Eastern Time, on December 17, 2019, or as soon thereafter as practicable or at such later time as
the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S.
Securities and Exchange Commission.
We would appreciated
it if, as soon as the Registration Statement is declared effective, you would so inform Rob R. Carlson of Sidley Austin LLP
at (650) 565-7129.
Very truly yours,
/s/ Anthony J. Bergmann
Anthony J. Bergmann
Chief Financial Officer
cc:
Linda Marbán, Chief Executive Officer, Capricor Therapeutics,
Inc.
Karen G. Krasney, General Counsel, Capricor Therapeutics, Inc.
Rob R. Carlson, Sidley Austin LLP
Nick DeAngelis, Sidley Austin LLP
Michael F. Nertney, Ellenoff Grossman & Schole LLP
Robert F. Charron, Ellenoff Grossman & Schole LLP
Charles Phillips, Ellenoff Grossman & Schole LLP
Matthew B. McCullough, Ellenoff Grossman & Schole LLP